Skip to main content
. Author manuscript; available in PMC: 2020 Oct 5.
Published in final edited form as: HPB (Oxford). 2018 Aug 4;21(3):345–351. doi: 10.1016/j.hpb.2018.07.014

Table 1:

Baseline and operative characteristics

West (n=210) East (n=164) P-value
Age, median (IQR) 65 (56–71) 68 (64–73) < 0.001
Male gender, n (%) 141 (67) 116 (71) 0.501
BMI, kg/m2, median (IQR) 25 (23–28) 22 (21–24) < 0.001
ASA score, n (%)
1
2
3
4

32 (15)
116 (55)
60 (29)
2 (1)

28 (17)
127 (77)
9 (6)
0 (0)
< 0.001
Bilirubin at presentation, μmol/L, median (IQR) 68 (19–197) 57 (27–144) 0.962
Jaundice at presentation, n (%) 154 (73) 82 (50) < 0.001
Directly preoperative bilirubin, μmol/L, median
(IQR)
15 (9–32) 14 (10–21) 0.170
Preoperative biliary drainage, n (%)
None
Percutaneous
Endoscopic
Both

40 (19)
29 (14)
84 (40)
57 (27)

20 (12)
14 (9)
115 (70)
15 (9)
< 0.001
Preoperative cholangitis, n (%) 68 (32) 65 (40) 0.193
Total liver volume, mL, median (IQR) 1863 (1539–2112) 1147 (1016–1310) < 0.001
Future liver remnant volume, mL, median (IQR) 956 (650–1318) 583 (490–723) < 0.001
Future liver remnant share, %, median (IQR) 50 (35–74) 49 (43–63) 0.823
Portal vein embolization, n (%) 14 (7) 90 (55) < 0.001
Type of resection, n (%)
Left hemihepatectomy
Extended left hemihepatectomy
Right hemihepatectomy
Extended right hemihepatectomy
Central hepatectomy or segmentectomy

81 (39)
20 (10)
43 (21)
60 (29)
6 (3)

54 (33)
12 (7)
91 (56)
5 (3)
2 (1)
< 0.001
Portal vein reconstruction, n (%) 42 (20) 93 (57) < 0.001
Hepatic artery reconstruction, n (%) 0 (0) 18 (11) < 0.001